Show simple item record

Determination and exploration the Quality of life and treatment satisfaction in patients with Type I diabetic using subcutaneous insulin multiple daily injections.

dc.contributor.authorAlsuwaydi, Mohammed
dc.contributor.authorAlobaidy, Retaj
dc.contributor.authorAlkumti, Nuha
dc.contributor.authorSalim Aldeen, Samah
dc.contributor.authorAmhimmid, Naelah
dc.contributor.authorHabib, Hana
dc.date.accessioned2022-08-11T16:45:39Z
dc.date.available2022-08-11T16:45:39Z
dc.date.issued2022-07-27
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/3902
dc.description.abstractBackground: Diabetes represents a major health problem because of its high prevalence, morbidity and mortality, its influence on patient quality of life, and its impact on the health system (1). This impact involves the physical and emotional overload of diabetes, a disease that requires life-long treatment, including lifestyle and pharmacological measures, often with multiple drugs. Quality of life QoL is regarded as a subjective measure of health and well-being related to a disease (2). Treatment satisfaction is a subjective measure that evaluates the patient’s experience of the processes and results of treatment. Further, it is known that poor satisfaction with treatment compromises treatment adherence (2). Aim: The aim of this case-control study was to determine and explore the quality of life (QoL) and treatment satisfaction in patients with Type 1 diabetes (T1DM) treated subcutaneous insulin multiple daily injections (MDI). Method: Consecutive patients aged between 18 and 55 years, and attending diabetes clinics for a routine visit, completed the Diabetes-Specific Quality-of-Life Scale (DSQOLS), the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and the SF-36 Health Survey (SF-36). Results: the result of this study shows that there is no difference distribution between gender 53.3% males and 46.7 females. Moreover, the largest percentage of age was between 46-55 (50%), the patients' satisfaction presented at higher percent between male 81.3%, graduate 40% and aged 2635 (80.0%). Conclusion: To conclude, diabetes type 1 is a common condition and it consider as an important public health concern, that significantly increases the risk of health problems. Health related quality of life (HRQOL) consider as a multi-dimensional concept that includes domains related to the effect of both physical and mental health perception and their correlate such as the health risks and conditions.en_US
dc.language.isoenen_US
dc.publisherFaculty of Pharmacyen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleDetermination and exploration the Quality of life and treatment satisfaction in patients with Type I diabetic using subcutaneous insulin multiple daily injections.en_US
dc.typeArticleen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States